BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10897789)

  • 1. [Corticoids in intestinal inflammatory diseases: use].
    Modigliani R
    Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B169-77. PubMed ID: 10897789
    [No Abstract]   [Full Text] [Related]  

  • 2. Refractory inflammatory bowel disease in children.
    Oliva-Hemker M; Escher JC; Moore D; Dubinksy M; Hildebrand H; Koda YK; Murch S; Sandhu B; Seo JK; Tanzi MN; Warner B;
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):266-72. PubMed ID: 18664886
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J; Niemelä S
    Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases].
    Kruis W; Pohl C
    Dtsch Med Wochenschr; 1998 Jan; 123(4):85-7. PubMed ID: 9487288
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of infliximab in Brazilian children and adolescents with Crohn disease and ulcerative colitis according to clinical manifestations, activity indices of inflammatory bowel disease, and corticosteroid use.
    Tiemi J; Komati S; Sdepanian VL
    J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):628-33. PubMed ID: 20386321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changing treatment of inflammatory bowel diseases].
    Karvonen AL; Matikainen M; Turunen U
    Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines for the management of inflammatory bowel disease in adults.
    Carter MJ; Lobo AJ; Travis SP;
    Gut; 2004 Sep; 53 Suppl 5(Suppl 5):V1-16. PubMed ID: 15306569
    [No Abstract]   [Full Text] [Related]  

  • 8. [Budesonide: effective, with low side effects. On the road to new treatment methods in Crohn disease].
    Internist (Berl); 1998 Sep; 39(9 Suppl Auf Dem We):1-8. PubMed ID: 9772715
    [No Abstract]   [Full Text] [Related]  

  • 9. [Budesonide and inflammatory bowel disease].
    Gomollón F; Hinojosa J; Nos P
    Gastroenterol Hepatol; 1999 Dec; 22(10):525-32. PubMed ID: 10650668
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation?
    Zlatanic J; Korelitz BI; Wisch N; Kim P; Ammirati M; Schwarz S; Gruenstein S; Lipsey L
    Am J Gastroenterol; 1997 Dec; 92(12):2285-8. PubMed ID: 9399771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extraintestinal manifestations in inflammatory bowel disease].
    Larsen S; Bendtzen K; Nielsen OH
    Ugeskr Laeger; 2009 Oct; 171(43):3078-83. PubMed ID: 19852894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology and ulcerative colitis.
    Ponichtera PB; Fitzgerald MA
    Clin Excell Nurse Pract; 1998 Mar; 2(2):67-72. PubMed ID: 10451266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.
    Mossop H; Davies P; Murphy MS
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):123-9. PubMed ID: 18664861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature.
    Peyrin-Biroulet L
    Am J Gastroenterol; 2013 May; 108(5):859-60. PubMed ID: 23644972
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical treatment and management of severe ulcerative colitis.
    Rizzello F; Campieri M; Tambasco R; Straforini G; Brugnera R; Poggioli G; Gionchetti P
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S280-4. PubMed ID: 18599001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic inflammatory bowel diseases. Do antihistaminics reduce the need for steroids?].
    MMW Fortschr Med; 2000 Jun; 142(22):59. PubMed ID: 10870388
    [No Abstract]   [Full Text] [Related]  

  • 18. The state of the art in the management of inflammatory bowel disease.
    Hanauer SB; Present DH
    Rev Gastroenterol Disord; 2003; 3(2):81-92. PubMed ID: 12776005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to?
    Gearry RB; Irving PM
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1160-2. PubMed ID: 19682189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of colitis ulcerosa and Crohn's disease].
    Kovács A
    Orv Hetil; 2006 Apr; 147(16):755-8. PubMed ID: 16711262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.